Chemoinformaics analysis of 2-HYDROXY-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-3-ONE
Molecular Weight | 165.148 | nRot | 0 |
Heavy Atom Molecular Weight | 158.092 | nRig | 12 |
Exact Molecular Weight | 165.043 | nRing | 2 |
Solubility: LogS | -2.225 | nHRing | 1 |
Solubility: LogP | 0.714 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 21.5336 |
nHD | 2 | BPOL | 10.1964 |
QED | 0.582 |
Synth | 2.893 |
Natural Product Likeliness | 1.056 |
NR-PPAR-gamma | 0.026 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.085 |
HIA | 0.011 |
CACO-2 | -5.02 |
MDCK | 0.00000712 |
BBB | 0.803 |
PPB | 0.462588 |
VDSS | 0.767 |
FU | 0.47076 |
CYP1A2-inh | 0.405 |
CYP1A2-sub | 0.292 |
CYP2c19-inh | 0.116 |
CYP2c19-sub | 0.752 |
CYP2c9-inh | 0.04 |
CYP2c9-sub | 0.747 |
CYP2d6-inh | 0.014 |
CYP2d6-sub | 0.659 |
CYP3a4-inh | 0.013 |
CYP3a4-sub | 0.226 |
CL | 2.373 |
T12 | 0.828 |
hERG | 0.009 |
Ames | 0.372 |
ROA | 0.315 |
SkinSen | 0.757 |
Carcinogencity | 0.307 |
EI | 0.395 |
Respiratory | 0.693 |
NR-Aromatase | 0.014 |
Antiviral | No |
Prediction | 0.83711 |